Evidence map›Paper›PMID 41346557›Full record

ArticleInternational journal of trichology

Can Serum UL16 Binding Protein 3 Tell Us More about Tinea Capitis?

Doaa M Elhabak, Mennat Allah A Ghazala, Menha Abd El-Fatah Ibrahim, Asmaa A El-Fallaha, Amany Kasem Shahat, Hanaa Eid

Abstract read
In one paragraph

Article in International journal of trichology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Doaa M ElhabakDepartment of Dermatology, Venereology and Andrology, Faculty of Medicine, Benha University, Benha, Egypt.
Mennat Allah A GhazalaDepartment of Dermatology, Venereology and Andrology, Faculty of Medicine, Benha University, Benha, Egypt.
Menha Abd El-Fatah IbrahimDepartment of Dermatology, Venereology and Andrology, Faculty of Medicine, Benha University, Benha, Egypt.
Asmaa A El-FallahaDepartment of Clinical and Chemical Pathology, Faculty of Medicine, Benha University, Benha, Egypt.
Amany Kasem ShahatDepartment of Medical Microbiology and Immunology, Faculty of Medicine, Benha University, Benha, Egypt.
Hanaa EidDepartment of Dermatology, Venereology and Andrology, Faculty of Medicine, Benha University, Benha, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The most frequent pediatric dermatophyte infection globally is tinea capitis (TC). Hair follicles have a variety of immunological defense mechanisms to stop infections from entering it. Natural-killer group 2, member D receptor ligands include unique long binding protein 3 (ULBP3) has a significant impact on the regulation of immunological reactions that are innate and adaptive. Objectives: The objective of this study was to evaluate the serum level of ULBP3 in patients with TC, its clinical significance, relation to types of dermatophytes, disease severity, and pathogenesis. Materials and Methods: There were 60 TC patients and 30 normal subjects in this case-control study. A culture of hair samples was done on Sabouraud dextrose agar with cycloheximide to know the type of dermatophyte, and the serum level of ULBP3 was done using ELIZA. Results: TC patients reported substantially higher plasma ULBP3 concentrations than healthy controls ( Conclusions: Serum ULBP3 might be involved in TC pathogenesis. Moreover, ULBP3 serum level could be considered a standalone risk predictor for TC susceptibility, activity, and severity.

Indexed as

Hair folliclesimmunitytinea capitisunique long binding protein 3

Identifiers

PMID41346557
PMCPMC12674503

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.